Clinical Monitoring

Leading Clinical Research combines its excellent knowledge of the local clinical trial market with high quality performance of clinical monitoring for clinical trials phase II through IV and clinical investigations.

We have gained first-class expertise in studies on pharmaceuticals, medical devices or their combinations. LCR offers services of its regional clinical monitoring staff, who are able to perform on-site visits in a highly cost-effective manner:

  • Site qualification visits
  • Site initiation visits
  • On-site monitoring
  • Adaptive monitoring
  • Site closure visits

As cost-effectiveness plays more and more important role in clinical research, LCR employees Risk Based Monitoring - a progressive method supported also by FDA allowing to achieve both time and cost savings by reducing source data verification (SDV) through a risk-based approach and therefore reducing the number of monitoring visits.